Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1225 of 5804
-
Can a cervical liquid zap persistent HPV? new trial aims to find out
Disease control Recruiting nowThe effectiveness of Patellin ® antibacterial solution in treating persistent cervical HR-HPV infection
Phase: PHASE4 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New registry aims to save lives from opioid overdoses in ERs
Knowledge-focused Recruiting nowUnregulated opioids remain a leading driver of preventable mortality and potential years of life lost in Canada. Emergency departments (EDs)-open 24/7 and frequently accessed by people who use drugs-offer critical opportunities to reverse toxicity, mitigate harm, and initiate tre…
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New asthma drug WIN378 aims to calm lung inflammation in phase 2 trial
Disease control OngoingThis study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate or severe asthma. WIN378 blocks the action of a protein called TSLP which causes inflammation in the lung and may contribute to your asthma control and symptoms. The s…
Phase: PHASE2 • Sponsor: Windward Bio • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New antibiotic combo aims to cut treatment time for stubborn lung infection
Disease control Recruiting nowThe goal of this clinical trial is to learn if adding contezolid works to shorten the length of treatment in mycobacterium avium pulmonary disease in adults. It will also learn about the safety of extended usage of contezolid. The main questions it aims to answer are: Does addin…
Phase: PHASE4 • Sponsor: Bin Cao • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New anemia pill for dialysis patients tested against standard shots
Disease control OngoingThis is a multi-center, randomized (1:1), open-label, active-controlled, pragmatic study of the efficacy of vadadustat administered three times a week compared to standard of care erythropoiesis-stimulating agent for the treatment of anemia in in-center hemodialysis participants …
Phase: PHASE3 • Sponsor: Akebia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for AML patients in india: drug combo aims for remission without intensive chemo
Disease control Recruiting nowAcute myeloid leukemia (AML) is one of the most aggressive blood cancers, with a very low survival rate and few options for participants who are unable to undergo standard induction therapy, the current standard of care. This study will assess the change in disease activity and a…
Phase: PHASE4 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Digital navigator aims to cut financial toxicity for young adults with cancer
Symptom relief Recruiting nowAim 1: Refine the HRSN navigation model to integrate a digital platform (Findhelp.org) to meet the needs of AYAs. The investigators will conduct iterative co-design sessions with AYAs and caregivers to understand their views on the existing Findhelp.org website and the likely nee…
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Gene therapy trial hopes to tackle muscle disease
Disease control Recruiting nowThis is a Phase 1/Phase 2 open-label single arm, multicenter, and multinational study with SAR446268 for treatment of male and female participants 10 to 55 years old with non-congenital myotonic dystrophy (DM) type 1 (DM1). The purpose of this study is to evaluate the safety and…
Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Brain zaps may help Parkinson's patients stay steady on their feet
Symptom relief Recruiting nowPostural instability is one of the cardinal signs in Parkinson's disease (PD). It represents one of the most disabling symptoms in the advanced stages of the disease. It is associated with frequent falls and loss of independence. The aim of the current study is to assess the long…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New study puts omnipod 5 to the test in Real-World diabetes management
Disease control OngoingThe purpose of this postmarket clinical investigation is to evaluate the levels of glycemic control, quality of life, and satisfaction, as well as the patient experience, and acute diabetes complication rates provided by the Omnipod 5 Automated Insulin Delivery System (referred t…
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a common diabetes drug help obese nigerians lose weight?
Disease control Recruiting nowObesity is a chronic disease of global public health concern, contributing to cardiovascular disease, type 2 diabetes and certain cancers. Currently approved anti-obesity drugs and surgery are expensive and not readily available in Nigeria. Metformin, approved for type 2 diabete…
Phase: PHASE3 • Sponsor: University Of Nigeria Teaching Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Less radiation, same control? new trial aims to boost quality of life for throat cancer patients
Disease control Recruiting nowThe goal of this study is to evaluate if a shorter course of therapy can improve the quality of life in patients receiving radiation therapy after trans-oral robotic surgery.
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New hope for Hard-to-Treat myeloma: experimental drug surzetoclax enters human trials
Disease control Recruiting nowMultiple myeloma (MM) is a plasma cell disease characterized by the growth of clonal plasma cells in the bone marrow. The purpose of this study is to assess the safety and change in disease activity of surzetoclax in adult participants with relapsed/refractory (R/R) MM. Adverse e…
Phase: PHASE1, PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could CBD help curb alcohol cravings? new trial investigates
Disease control Recruiting nowAlcohol addiction (AD) is a chronic relapsing disorder with currently limited pharmacological treatment options. Alcohol craving, a hallmark symptom of AD that drives relapse in patients, is only insufficiently treated by existing medication. One promising new compound for the tr…
Phase: PHASE2 • Sponsor: Central Institute of Mental Health, Mannheim • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study monitors OBIZUR's safety in rare bleeding disorder
Disease control Recruiting nowAcquired hemophilia A (AHA) is a rare bleeding condition which prevents blood clotting. Acquired means that people are not born with this condition or have a family history of blood clotting conditions. People living with AHA can have sudden and severe bleeding. They also have lo…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New oral drug targets Hard-to-Treat cancers with missing gene
Disease control Recruiting nowThis is a first-in-human (FIH), multicenter, non-randomized, openlabel, phase 1 study of ABSK131 in patients with MTAP-Deficient Advanced/Metastatic Solid Tumors to evaluate the safety, tolerability, PK, and preliminary antitumor efficacy.
Phase: PHASE1 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New wearable tech aims to ease swallowing troubles for stroke and Parkinson's patients
Symptom relief Recruiting nowDysphagia, or difficulty swallowing, is a common symptom of many neurological diseases but its treatment is not well established or easily accessible. To start addressing this gap, the researchers developed and validated a cost-effective wearable surface electromyography (sEMG) …
Phase: PHASE2 • Sponsor: Purdue University • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New cancer drug VIR-5525 enters first human trials for EGFR-Positive tumors
Disease control Recruiting nowThis Phase 1, first-in-human (FIH), dose-escalation and dose-expansion study is designed to evaluate the safety, PK, and preliminary anti-tumor activity of VIR-5525 as a monotherapy and in combination with pembrolizumab in participants with solid tumors that are known to express …
Phase: PHASE1 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis is a multicenter, open-label Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary clinical efficacy of HY05350 for injection in patients with MSLN-positive advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug FORX-428 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThe goal of this interventional study is to evaluate the safety and tolerability of escalating doses of FORX-48 as monotherapy in patients with select advanced solid tumors with BRCA1/2 mutations or other DDR deficiencies or high replication stress, and to determine the maximum t…
Phase: PHASE1 • Sponsor: FoRx Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC